WaveClear Raises $1.125 Million in Series A Funding Led by Hunniwell

WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications.

WaveClear Raises $1.125 Million in Series A Funding Led by Hunniwell2020-10-13T01:33:56+00:00

Hunniwell at the Spring 2020 F50 Global Capital Summit

Hunniwell Lake Ventures (HLV) is pleased to sponsor this year’s Spring F50 Global Capital Summit, June 16-17, 2020. Watch HLV partners give talks, host live roundtables, speak on panels and judge startups.

Hunniwell at the Spring 2020 F50 Global Capital Summit2020-07-15T23:02:07+00:00

Four Industry Veterans Join Hunniwell

Hunniwell Lake Ventures is pleased to gain the strategic counsel of these talented, highly experienced and successful professionals - David Schechter, David Cao, John Ashley and Matt Otten - as they help us achieve our mission towards Intelligent Surgery.

Four Industry Veterans Join Hunniwell2020-07-15T22:55:20+00:00

Hunniwell Shares Insights with UCLA BioDesign Program

 Hunniwell Lake Ventures Managing Partner Daniel Teo shares keen advice with the inaugural class of 2020 Fellows in the UCLA BioDesign Program in his presentation titled "Tales from the Other Side."

Hunniwell Shares Insights with UCLA BioDesign Program2020-12-07T21:28:31+00:00

Hunniwell Lake Ventures Joins Fight Against COVID

Hunniwell Lake Ventures joined 60 other experts in the medical device industry to help 15 selected startups accelerate the development and commercialization of their COVID-19 related solution.

Hunniwell Lake Ventures Joins Fight Against COVID2020-07-15T22:56:00+00:00

Hunniwell Lake Ventures

See. Treat. Heal.

Towards Intelligent Surgery.